2016: Chimeron Bio: KEI comments on NIH proposal for exclusive license for patents on cancer treatments
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 18th, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to Chimeron… Continue Reading